Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

483
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
483
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

279
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Historical Perspective of HER2 Testing and Treatment in Prostate Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

You get what you need: Implementation of electronic remote blood refrigerators to reduce inefficiencies in blood product allocation and massive transfusion protocol overactivation.

American journal of clinical pathology·2026
Same author

TP53 P72R Polymorphism Is Associated With P53 Protein Expression in Fatal Prostate Cancer: A Novel Case Report and Review of the Literature.

Cureus·2025
Same author

Exploring Global Opportunities in Pathology Journal Authorship: A Commentary Based on Income Level of Authors' Affiliation Country.

Archives of pathology & laboratory medicine·2025
Same author

Clinical response to novel combination of trastuzumab deruxtecan and abiraterone in HER2-expressing metastatic castration-resistant prostate cancer.

The oncologist·2025
Same author

Investigating Intensity and Percentage of p53 Nuclear Expression in Prostate Cancer: Findings from a Cohort of U.S. Military Veterans.

Cancers·2025

Related Experiment Video

Updated: Jun 3, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.4K

Retooling the Massive Transfusion Protocol at a Veterans Affairs Medical Center.

Stevephen Hung1, Richard Carpenay2, Xiomara Fernandez1

  • 1Department of Pathology, The George Washington University Hospital, Washington, DC 20037, USA.

Military Medicine
|January 9, 2025
PubMed
Summary

Policy improvements to massive transfusion protocols (MTPs) reduced unjustified activations by enhancing clinician training. This optimization improved blood stewardship and resource allocation without impacting patient outcomes.

More Related Videos

A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research
09:09

A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research

Published on: October 14, 2013

12.4K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.4K
A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research
09:09

A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research

Published on: October 14, 2013

12.4K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.8K

Area of Science:

  • Medical Sciences
  • Hematology
  • Emergency Medicine

Background:

  • Massive transfusion protocols (MTPs) are critical for managing exsanguination but are resource-intensive.
  • Balancing hospital resources with patient needs and avoiding unjustified MTP activations is essential for effective implementation.
  • Policy improvements were implemented to ensure appropriate clinical activation of MTPs.

Purpose of the Study:

  • To evaluate the effects of revamped MTP policies on activation frequency, characteristics, and patient outcomes.
  • To assess the impact of enhanced clinician training and streamlined ordering processes on MTP utilization.
  • To determine if policy changes led to a reduction in unjustified MTP activations.

Main Methods:

  • A retrospective study was conducted comparing MTP activations before and after policy changes in Spring 2019.
  • Key changes included mandatory attending/fellow approval for MTP activations and enhanced clinician training.
  • Statistical analyses included descriptive statistics, Fisher exact test, Wilcoxon test, and Poisson test.

Main Results:

  • No statistically significant changes were observed in patient parameters or survival outcomes post-policy implementation.
  • A decreasing trend in MTP activations was noted.
  • A significant increase in the median days between MTP activations was observed, from 12.5 to 41 days (P=0.0274).

Conclusions:

  • The tailored MTP effectively provides blood products for genuine massive transfusion needs while reducing unjustified activations.
  • Improved clinician education and training were credited with changing ordering behaviors and reducing unnecessary MTP activations.
  • This strategy enhances blood stewardship by minimizing resource wastage and preserving staff time for critical patient care.